首页> 外文期刊>The journal of sexual medicine >Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.
【24h】

Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.

机译:体重指数调节性腺功能减退相关的CV风险:这是一组勃起功能障碍患者的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Obesity is an independent cardiovascular (CV) risk factor. Testosterone (T) is inversely related to body mass index (BMI) in males. There is substantial evidence suggesting that low T could play a role as a moderator of CV mortality in men. AIM: This study is designed to assess the possible interaction between T and obesity in predicting major CV events (MACE) in a sample of subjects with erectile dysfunction. METHODS: A consecutive series of 1,687 patients were studied. Different clinical, biochemical, and instrumental parameters were evaluated. According to BMI, subjects were divided into normal weight (BMI = 18.5-24.9 kg/m(2) ), overweight (BMI = 25.0-29.9 kg/m(2) ), and obese (BMI >/= 30.0 kg/m(2) ). Hypogonadism was defined as total T below 10.4 nmol/L. Information on MACE was obtained through the City of Florence Registry Office. MAIN OUTCOME MEASURES: Information on MACE was obtained through the City of Florence Registry Office. RESULTS: Among the patients studied, 39.8% had normal weight, whereas 44.1% and 16.1% were overweight and obese, respectively. Unadjusted analysis in the whole sample showed that while hypogonadism and obesity were significantly associated with an increased risk of MACE, their interaction term was associated with a protective effect. In a Cox regression model, adjusting for confounders, hypogonadism showed a significant increased risk of MACE in normal weight subjects, whereas it was associated with a reduced risk in obese patients. CONCLUSIONS: Hypogonadism-associated CV risk depends on the characteristics of subjects, being more evident in normal weight than in obese patients. Further studies are advisable to clarify if low T in obese patients is a (positive) consequence of a comorbid condition (i.e., to save energy) or if it represents a pathogenetic issue of the same illness. Hence, possible misuse/abuse of T treatment in obese subjects must be avoided.
机译:简介:肥胖是独立的心血管(CV)危险因素。男性的睾丸激素(T)与体重指数(BMI)成反比。有大量证据表明,低T可能充当男性CV死亡率的调节剂。目的:本研究旨在评估勃起功能障碍受试者样本中T与肥胖之间的相互作用,以预测主要心血管事件(MACE)。方法:连续研究了1687例患者。评估了不同的临床,生化和仪器参数。根据BMI,受试者分为正常体重(BMI = 18.5-24.9 kg / m(2)),超重(BMI = 25.0-29.9 kg / m(2))和肥胖(BMI> / = 30.0 kg / m (2))。性腺功能减退被定义为总T低于10.4 nmol / L。有关MACE的信息是通过佛罗伦萨市登记处获得的。主要观察指标:关于MACE的信息是通过佛罗伦萨市登记处获得的。结果:在研究的患者中,体重正常的占39.8%,而超重和肥胖的分别为44.1%和16.1%。整个样本中未经调整的分析表明,性腺功能减退和肥胖症与MACE风险增加显着相关,但它们的相互作用期限与保护作用相关。在校正混杂因素的Cox回归模型中,性腺机能减退表明正常体重受试者的MACE风险明显增加,而与肥胖患者的风险降低有关。结论:与性腺机能减退相关的心血管风险取决于受试者的特征,在正常体重中比在肥胖患者中更为明显。建议进行进一步的研究以阐明肥胖患者的低T是否是合并症(节省能量)的(阳性)结果,还是代表同一疾病的致病性问题。因此,必须避免在肥胖受试者中可能滥用/滥用T治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号